Korea United Pharmaceutical Incorporated - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Korea United Pharmaceutical Incorporated. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Korea United Pharmaceutical Incorporated. The Company's principal activities are manufacturing and distributing pharmaceuticals. The Company's core offerings include anticancer drugs for cancer of digestive organ, breast and ovary, malignant tumor and myelogenous leukemia; antibiotics for various infection; circulatory drugs used to treat hypertension, stenocardia, diabetes and other disease of circulatory organ; vitamins for weak constitution and vitamin deficiency diseases; antifebrile and anodynes for arthritis, period pains and pain after surgery, and digestive system drugs used to cure gastric ulcer, gastritis, duodenal ulcer and others. The Company is also involved in the research and development of new drugs through its research center in Korea.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report